⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

Official Title: Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

Study ID: NCT01398085

Conditions

Thyroid Cancer

Interventions

I131 1.1 GBq

Study Description

Brief Summary: IoN is a phase II/ III trial that will look to ascertain whether or not radio-iodine ablation is necessary for low risk differentiated thyroid cancer patients.

Detailed Description: Phase II: to determine if recruitment into a phase III trial is feasible, with a target of 10 patients per month during a minimum of 6 months (evaluated within months 7-18 of the trial). Phase III: to determine whether the 5-year disease-free survival rate among patients who do not have routine Radioactive iodine (RAI) ablation is non-inferior to those who do.

Eligibility

Minimum Age: 16 Years

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University Hospitals Birmingham NHS Foundation Trust, Birmingham, , United Kingdom

Brighton and Sussex University Hospitals NHS Trust, Brighton, , United Kingdom

University Hospital Bristol NHS Foundation Trust, Bristol, , United Kingdom

Cambridge University Hospitals NHS Foundation Trust, Cambridge, , United Kingdom

East Kent Hospitals University NHS Foundation Trust, Canterbury, , United Kingdom

Mid Essex Hospitals Services NHS Trust, Chelmsford, , United Kingdom

Gloucestershire Hospitals NHS Trust, Cheltenham, , United Kingdom

Royal Derby hospital NHS foundation trust, Derby, , United Kingdom

NHS Lothian, Edinburgh, , United Kingdom

Royal Devon and Exeter NHS Trust, Exeter, , United Kingdom

Glasgow and Clyde NHS Trust, Glasgow, , United Kingdom

The Royal Surrey County Hospital NHS Foundation Trust, Guildford, , United Kingdom

Ipswich Hospital NHS Trust, Ipswich, , United Kingdom

Leeds Teaching Hospitals NHS Trust, Leeds, , United Kingdom

University Hospitals of Leicester NHS Trust, Leicester, , United Kingdom

Royal Marsden NHS Foundation Trust, London, , United Kingdom

Imperial College Healthcare NHS Trust, London, , United Kingdom

Barts Health NHS Trust, London, , United Kingdom

Guys and St Thomas' NHS Foundation Trust, London, , United Kingdom

University College London Hospitals NHS Foundation Trust, London, , United Kingdom

Maidstone and Tunbridge Wells NHS Trust, Maidstone, , United Kingdom

The Christie NHS Foundation Trust, Manchester, , United Kingdom

South Tees Hospitals NHS Trust, Middlesbrough, , United Kingdom

Velindre NHS Trust, Nantgarw, , United Kingdom

Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, , United Kingdom

Norfolk and Norwich University Hospitals NHS Trust, Norwich, , United Kingdom

Nottingham University Hospitals NHS Trust, Nottingham, , United Kingdom

Portsmouth Hospitals NHS Trust, Portsmouth, , United Kingdom

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, , United Kingdom

Southend University Hospitals NHS Trust, Southend, , United Kingdom

East and North Herts, Stevenage, , United Kingdom

Royal Wolverhampton NHS Trust, Wolverhampton, , United Kingdom

Contact Details

Name: Ujjal Mallick, MBBS, Master of Surgery, FRCR

Affiliation: Newcastle-upon-Tyne Hospitals NHS Foundation Trust

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: